These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15239213)

  • 21. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
    Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
    Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
    Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
    Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of Bcl-xL in human hepatocellular carcinoma.
    Watanabe J; Kushihata F; Honda K; Sugita A; Tateishi N; Mominoki K; Matsuda S; Kobayashi N
    Surgery; 2004 Jun; 135(6):604-12. PubMed ID: 15179366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
    Chung GG; Zerkowski MP; Ocal IT; Dolled-Filhart M; Kang JY; Psyrri A; Camp RL; Rimm DL
    Cancer; 2004 May; 100(10):2084-92. PubMed ID: 15139049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications.
    Pukkila MJ; Kumpulainen EJ; Virtaniemi JA; Johansson RT; Halonen PM; Kellokoski JK; Kosunen AS; Nuutinen J; Kosma VM
    Head Neck; 2002 Aug; 24(8):784-91. PubMed ID: 12203805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
    Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
    Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
    Torbenson M; Kannangai R; Abraham S; Sahin F; Choti M; Wang J
    Am J Clin Pathol; 2004 Sep; 122(3):377-82. PubMed ID: 15362367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
    J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma.
    Makino I; Chijiiwa K; Kondo K; Ohuchida J; Kai M
    Surgery; 2005 Jun; 137(6):626-31. PubMed ID: 15933630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.